Trade Recordati SPA - RECm CFD
Add to favourite- Summary
- Historical Data
Spread | 0.22 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.020029% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.002193% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | Italy | ||||||||
Commission on trade | 0% |
Prev. Close | 51.84 |
Open | 51.44 |
1-Year Change | 12.66% |
Day's Range | 50.94 - 51.74 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 15, 2024 | 50.99 | -0.30 | -0.58% | 51.29 | 51.74 | 50.89 |
Nov 14, 2024 | 51.84 | 0.25 | 0.48% | 51.59 | 51.99 | 51.09 |
Nov 13, 2024 | 51.39 | 0.80 | 1.58% | 50.59 | 51.54 | 50.49 |
Nov 12, 2024 | 51.19 | -0.95 | -1.82% | 52.14 | 52.49 | 51.14 |
Nov 11, 2024 | 52.09 | 0.80 | 1.56% | 51.29 | 52.24 | 50.79 |
Nov 8, 2024 | 50.84 | -1.10 | -2.12% | 51.94 | 52.34 | 48.49 |
Nov 7, 2024 | 52.09 | 0.60 | 1.17% | 51.49 | 52.24 | 51.49 |
Nov 6, 2024 | 51.69 | -0.05 | -0.10% | 51.74 | 52.44 | 51.49 |
Nov 5, 2024 | 51.54 | -0.40 | -0.77% | 51.94 | 52.14 | 51.39 |
Nov 4, 2024 | 51.99 | 0.20 | 0.39% | 51.79 | 52.54 | 51.79 |
Nov 1, 2024 | 52.44 | 0.65 | 1.26% | 51.79 | 52.69 | 51.79 |
Oct 31, 2024 | 51.94 | -0.35 | -0.67% | 52.29 | 52.89 | 51.59 |
Oct 30, 2024 | 53.19 | -0.20 | -0.37% | 53.39 | 53.69 | 52.99 |
Oct 29, 2024 | 53.94 | -0.10 | -0.19% | 54.04 | 54.39 | 53.84 |
Oct 28, 2024 | 54.09 | 0.60 | 1.12% | 53.49 | 54.19 | 53.49 |
Oct 25, 2024 | 53.49 | 0.00 | 0.00% | 53.49 | 53.79 | 53.29 |
Oct 24, 2024 | 53.74 | 0.30 | 0.56% | 53.44 | 53.79 | 53.29 |
Oct 23, 2024 | 53.39 | 0.35 | 0.66% | 53.04 | 53.79 | 52.94 |
Oct 22, 2024 | 53.44 | 0.00 | 0.00% | 53.44 | 53.79 | 52.84 |
Oct 21, 2024 | 53.79 | -0.10 | -0.19% | 53.89 | 54.34 | 53.79 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Recordati Company profile
About Recordati Industria Chimica e Farma SpA
Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Recordati Industria Chimica e Farma SpA revenues increased 9% to EUR1.58B. Net income increased 9% to EUR386M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Dividend per share increased from EUR1.05 to EUR1.10. Basic Earnings per Share excluding Extraordinary Items increased from EUR1.73 to EUR1.87.
Industry: | Pharmaceuticals (NEC) |
Via M. Civitali, 1
MILANO
MILANO 20148
IT
News
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024US elections: Trump leads the polls, but tariff talk spooks investors
As the US elections get closer we look at how Trump’s tariff plans could affect markets.
15:02, 22 October 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com